Search Tag: CNSystems
2024 09 Aug
Recent publications on triggers, symptoms, biomarkers, treatment and its association with post-COVID Myalgic encephalomyelitis (ME), better known as the Chronic Fatigue Syndrome (CFS) is a neuroimmunological multisystem disease affecting millions of people worldwide. The global prevalence of CFS ranges between 0.4% and 2.5% and is growing....Read more
2022 23 Dec
James Frith is a consultant physician and geriatrician in Newcastle, England. He is also a researcher at the Newcastle University. His academic interests focus on orthostatic hypotension, in particular, the non-drug treatments of orthostatic hypotension that significantly overlap with falls and syncope. HealthManagement. org spoke to Dr Frith on the...Read more
2021 08 Dec
The importance of continuous non-invasive cardiovascular monitoring and the use of CNAP®️ technology for haemodynamic optimisation to improve patient care and medical outcome. Read more
2021 20 Oct
Initial Orthostatic Hypotension (OH) is described as a rapid and transient drop in blood pressure associated with the increased risk of falls, fractures and syncope, especially in the ageing population (Tran et al. 2021). As prevalence is high, the problem is evident, but due to limited access to reliable continuous diagnostic methods, the detection...Read more
2021 01 Jun
Long COVID patients suffer from autonomic dysfunction with persistent long-term symptoms. CNSystems’ non-invasive technology significantly contributes to a well-founded cardiovascular diagnosis of COVID-19 survivors and enables a quick check of treatment efficacy. Key Points Many patients who survive acute COVID-19 infection suffer...Read more
2021 10 May
There is a high demand for a comfortable, small and mobile solution for affordable blood pressure and vital sign monitoring in the general ward to improve patient safety and outcome, as mortality after surgery is a thousand times higher than intraoperative death. 1 CNSystems has enhanced its non-invasive CNAP® technology for perioperative...Read more
2021 09 Apr
There is a high demand for a comfortable, small and mobile solution for affordable blood pressure and vital sign monitoring in the general ward to improve patient safety and outcome, as mortality after surgery is a thousand times higher than intraoperative death. 1 CNSystems has enhanced its non-invasive CNAP ® technology for perioperative care...Read more
2020 22 Oct
Syncope is a heterogeneous syndrome with complex underlying mechanisms. The spectrum of patients presenting with syncope is broad, which requires appropriate, often individualized diagnosis paths. “Patients presenting with syncope, a sudden transient loss of consciousness, require appropriate, often individualized diagnosis and...Read more
2020 14 Oct
We are happy to announce that to date our CNAP® technology for monitoring continuous blood pressure and hemodynamics has reached the magic mark of over 1,000 peer-reviewed publications. Our customers use CNAP® to collect data in over 100 studies and many more advanced research projects per year. Utilizing a simple finger sensor CNAP® provides a...Read more
2020 29 May
International experts treating COVID-19 patients have concluded that hemodynamic optimization plays a major role in the management of the complex interaction of respiratory and cardiovascular factors. CNSystems, a global market-leader for noninvasive hemodynamic monitoring, provides a tailor-made solution to support the diagnostic and therapy-guiding...Read more
2020 19 May
The rapid global distribution of COVID-19 is challenging healthcare systems worldwide. In many countries hospitals and ICU departments are overloaded or fear a potential collapse - the optimal allocation of healthcare resources is required. Healthcare professionals are forced to treat severely ill patients with limited access to ventilation equipment,...Read more
2019 13 Nov
Summary: Noninvasive, continuous haemodynamic assessment in clinically proven quality made easy. Easy-to-use and reliable methods for a clinically valuable cardiovascular assessment have become inevitable at a time when cardiovascular disease (CVD) is the number one cause of death 1 and postoperative complications causing long hospital stays...Read more
2019 26 Aug
How can we get the most common, costly, and modifiable cardiovascular risk factor under control? Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030, placing a significant economic burden on public healthcare services. 1,2,3 The most common risk factor...Read more
2019 07 Aug
Meet us at the T4 Physiology Conference from August 12-14 at the UCSB in Santa Barbara. "If you measure physiology from human subjects, or work with those who do, you should attend!" T4: Tools, Trends, Techniques and Technology by BIOPAC Learn more about the congress Learn more about CNSystems Read more
2019 30 May
How effective are less invasive or even noninvasive methods? The clinical and economic burden of post-surgical complications and the economic impact of Goal-Directed Fluid Therapy (GDFT) implementation. Improving the quality of care by reducing post-surgical complications, decreasing mortality, and decreasing hospital...Read more
2019 22 Feb
Aspects & challenges - Approaches & tools Head-up-tilt testing (HUTT) and autonomic function testing are essential diagnostic procedures in syncope assessment. With the advent of unique innovative methods to noninvasively monitor beat-to-beat blood pressure, cardiac output, total peripheral resistance as well as autonomic regulation, highly efficient...Read more
2019 06 Feb
Which is the horse and which is the jockey? Let us share some interesting study findings and aspects on the relation of autonomic function and neurological disorders: Neurological diseases are very often associated with autonomic dysfunction – or the other way round? Migraine, Multiple Sclerosis or Parkinson’s Disease are only a few...Read more